ArticleMolecular carcinogenesis2019

Serum miR-182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats.

Merricka C Livingstone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.